OncoCyte (NASDAQ:OCX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the stock. OCX has been the topic of several other reports. Needham & Company LLC cut their price objective on OncoCyte from $4.25 to $3.60 and set a […]
More Stories
Envestnet Portfolio Solutions Inc. Sells 3,709 Shares of Akamai Technologies, Inc. (NASDAQ:AKAM)
Envestnet Portfolio Solutions Inc. reduced its stake in Akamai Technologies, Inc. (NASDAQ:AKAM – Free Report) by 38.6% during the first...
Envestnet Portfolio Solutions Inc. Has $456,000 Position in Badger Meter, Inc. (NYSE:BMI)
Envestnet Portfolio Solutions Inc. increased its position in shares of Badger Meter, Inc. (NYSE:BMI – Free Report) by 46.5% in...
Envestnet Portfolio Solutions Inc. Acquires Shares of 18,942 Invesco Variable Rate Investment Grade ETF (NASDAQ:VRIG)
Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Invesco Variable Rate Investment Grade ETF (NASDAQ:VRIG – Free...
State of Alaska Department of Revenue Buys 85 Shares of Wingstop Inc. (NASDAQ:WING)
State of Alaska Department of Revenue raised its stake in shares of Wingstop Inc. (NASDAQ:WING – Free Report) by 2.5%...
AptarGroup, Inc. (NYSE:ATR) Shares Sold by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. reduced its holdings in AptarGroup, Inc. (NYSE:ATR – Free Report) by 25.9% during the 1st quarter,...
State of Alaska Department of Revenue Cuts Position in Victoria’s Secret & Co. (NYSE:VSCO)
State of Alaska Department of Revenue decreased its position in Victoria’s Secret & Co. (NYSE:VSCO – Free Report) by 2.4%...